Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.030
-0.030 (-2.83%)
At close: Dec 5, 2025, 4:00 PM EST
1.000
-0.030 (-2.91%)
After-hours: Dec 5, 2025, 7:16 PM EST
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $135.03 million as of December 5, 2025. Its market cap has increased by 156.36% in one year.
Market Cap
135.03M
Enterprise Value
110.99M
1-Year Change
156.36%
Ranking
Category
Stock Price
$1.03
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $135.03M, a decrease of -73.74%. That is a compound annual growth rate of -27.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 138.96M | 206.14% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |